SCHEMBL29397476

SCHEMBL29397476

O=C1CCC(=O)N(O)CC[C@H](O)CNC(=O)CCC(=O)N(O)CC[C@H](O)CN1

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
GAA P10253 1/20 0.50
POLB P06746 1/20 0.50
CDA P32320 1/20 0.37
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.33
APEX1 P27695 1/20 0.33
ENO1 P06733 1/20 0.31
CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1351576 0.77 NPC1 (0.41) KDM4EGAAPOLBCYP3A4TSHR
SCHEMBL1559274 0.76
SCHEMBL1559273 0.76
SCHEMBL1707434 0.76
SCHEMBL9068589 0.72
SCHEMBL32666026 0.68 KDM4E (0.96) KDM4EGAAPOLBCDACRBN
SCHEMBL29855407 0.68 KDM4E (0.96) KDM4EGAAPOLBCDACRBN
Nocardamine SCHEMBL3725976 0.67 KDM4E (1.00) KDM4EGAAPOLBCDACRBN
SCHEMBL32666021 0.67 KDM4E (1.00) KDM4EGAAPOLBCDACRBN
Desmethylenylnocardamine SCHEMBL32666030 0.67 KDM4E (1.00) KDM4EGAAPOLBCDACRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4520775-B1 NITROGEN-CONTAINING HETEROCYCLIC POLYMER, AND POLYMER FILM AND USE THEREOF WUHAN LIMO TECH CO LTD (CN) 2026-05-06 EP claimed
EP-4460536-B1 BIO-BASED ADHESIVE FOR ELECTRICAL INSULATION INDIAN INSTITUTE OF TECH IIT MADRAS (IN) 2025-11-19 EP claimed
EP-4223749-B1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD (CN) 2025-08-06 EP claimed
US-12365945-B2 Urinary microbiomic profiling Convergent Genomics, Inc. (US) 2025-07-22 US claimed
US-20250009891-A1 CONJUGATES OF MONOCYCLIC BETA-LACTAMS AND SIDEROPHORE MIMETICS UNIVERSITY OF NOTRE DAME DU LAC 2025-01-09 US claimed
EP-4061970-B1 PROCESS FOR DEHAIRING AND LIMING OF HIDES, SKINS OR PELTS STAHL INT B V (NL) 2024-12-25 EP claimed
EP-4151629-B1 METHOD FOR PREPARING RACEMIC NICOTINE SHENZHEN ZINWI BIO TECH CO LTD (CN) 2024-10-23 EP claimed
CN-118272892-A Electrolyte and hard alloy processing method 财团法人金属工业研究发展中心 2024-07-02 CN claimed
EP-4227290-B1 DMF RECYCLING METHOD ANHUI JINHE IND CO LTD (CN) 2024-05-22 EP claimed
EP-3858829-B1 METHOD FOR PREPARING ISOXAZOLINE-CONTAINING URACIL COMPOUND BY METHYLATION SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD (CN) 2024-05-01 EP claimed
EP-3068862-B1 METHOD FOR PRODUCING SOAP FROM FATTY AND RESIN ACIDS, AND A SOAP COMPOSITION THEREOF FORCHEM OYJ (FI) 2024-04-17 EP claimed
EP-3783008-B1 A METHOD FOR TREATING LIGNIN AND FOR PRODUCING A BINDER COMPOSITION UPM KYMMENE CORP (FI) 2023-09-27 EP claimed
EP-3656881-B1 PROCESS AND SYSTEM FOR PRODUCING ALUMINA FROM BAUXITE ORE ALUNORTE ALUMINA DO NORTE DO BRASIL S A (BR) 2023-06-14 EP claimed
EP-3913130-B1 REACTIVE DYE MOISTURE FIXATION CONTINUOUS DYEING METHOD HUAFANG CO LTD (CN) 2023-06-07 EP claimed
EP-3946722-B1 METHOD FOR RECOVERING METAL IONS FROM INDUSTRIAL WASTE WATER, AND THEREWITH ASSOCIATED USE OF A COMPLEXING AGENT HELMHOLTZ ZENTRUM DRESDEN (DE) 2023-04-26 EP claimed
EP-3240632-B1 A METHOD FOR THE SYNTHESIS OF A TYPE OF FER/MOR COMPOSITE MOLECULAR SIEVE DALIAN INST CHEM & PHYSICS CAS (CN) 2023-03-22 EP claimed
EP-3912978-B1 PREPARATION METHOD FOR MORPHOLINQUINAZOLINE COMPOUND AND MIDBODY THEREOF SHANGHAI YINGLI PHARM CO LTD (CN) 2023-02-15 EP claimed
CN-114486723-A Method for verifying binding performance of basalt reinforced alkali-activated concrete 武汉理工大学 2022-05-13 CN claimed
WO-2026085618-A1 METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION YYZ PHARMATECH INC. (CA) 2026-04-30 WO disclosed
CN-109121438-B Semiconductor device and display device including the same 株式会社半导体能源研究所 2022-02-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009891-A1 CONJUGATES OF MONOCYCLIC BETA-LACTAMS AND SIDEROPHORE MIMETICS MGAM, OPRM1, BPGM KDM4E 1593/4885GAA 210/4885POLB 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.